The phrase “NAD+ precursor” does not identify one product or one safety profile. Before deciding whether liver tests are relevant, the exact ingredient and formulation need to be clear.[1]
Nicotinic acid, a form of niacin, has well-described liver risks at high supplemental amounts. Other NAD-related compounds need their own safety assessment.[1]
What is established for nicotinic acid?
The NIH Office of Dietary Supplements describes liver toxicity with high-dose nicotinic acid used over months or years. Reported effects include elevated liver enzymes and, in severe cases, liver injury. Extended-release forms carry particular concern.[1]
The fact sheet discusses clinical monitoring of liver enzymes in that context. It is not a universal screening protocol for every product marketed for cellular energy.[1]
What do the liver measurements mean?
A comprehensive metabolic panel includes ALT, AST, alkaline phosphatase, bilirubin and albumin. These contribute different information to liver assessment and are interpreted with the rest of the panel, health history and medicines.[2]
An abnormal enzyme result usually creates a question about its cause. It does not identify a supplement as the cause without a timeline and broader evaluation.[2][3]
What about newer precursors?
A small randomized trial of oral nicotinamide riboside found it was well tolerated during the study and increased NAD+ metabolism. Its short duration and selected participants limit what it can establish about long-term use or people with existing liver disease.[4]
Bring the exact label, other supplements, medicines and any previous liver results to the discussion. The useful answer explains whether testing is indicated for that ingredient and your circumstances, what a result would change, and what follow-up would mean.
